Industry Analysis, ECS Digital Resources • April 23, 2024
New research released by Vital Transformation (VT) shows that the Inflation Reduction Act (IRA) will stifle the ability of companies to continue research and development across a broad range of therapeutic areas.
Industry Analysis, ECS Digital Resources • April 23, 2024
This report investigates recent investment into antibacterial innovation and the current clinical pipeline that will help bridge the gaps in the antibacterial armamentarium.
Today is Earth Day, highlighting the importance of addressing plastic pollution—and biotech has a few answers. Continuing on the environment theme, BIO’s Beth Ellikidis spoke to Agri-Pulse about how we can advance biotech innovation. (546 words, 2 minutes, 43 seconds)
Human Health • Letters, Testimony & Comments • April 19, 2024
The Biotechnology Innovation Organization appreciates the opportunity to comment on the Center for Medicare and Medicaid Services’ Information Collection Request on the Part C and Part D Medicare Prescription Payment Plan Model Documents.
In response to their advance notice of proposed rulemaking (ANPRM), BIO submitted comments to the DOJ's National Security Division on implementing the White House Executive Order of February 28, 2024, “Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern.”
A busy week comes to an end with a recap of what policymakers and regulators said at yesterday’s Agriculture & Environment Summit, plus more news you might have missed. (795 words, 3 minutes, 58 seconds)
A busy week continues, as we kick off the BIO Agriculture & Environment Summit, and recap BIO’s Capitol Hill fly-in. Plus, a new report highlights the societal value of vaccines. (634 words, 3 minutes, 10 seconds)
